Lista de obras -

A quantitative, single-cell PCR analysis of an antigen-specific TCR repertoire selected during an in vivo CD8 response: direct evidence for a wide range of clone sizes with uniform tissue distribution.

artículo científico publicado en 1999

Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset.

artículo científico publicado en 1999

B7-homolog 1 expression by human glioma: a new mechanism of immune evasion.

artículo científico publicado en 2005

Brain tumor immunotherapy: Illusion or hope?

artículo científico publicado en 2017

Cell-penetrating peptides-the Swiss Army knife of cancer vaccines.

artículo científico publicado en 2015

Cutting edge: cross-presentation as a mechanism for efficient recruitment of tumor-specific CTL to the brain.

artículo científico publicado en 2003

Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing

artículo científico publicado en 2016

ER-mitochondria contacts control surface glycan expression and sensitivity to killer lymphocytes in glioma stem-like cells.

artículo científico publicado en 2017

Efficient induction of CD8 T-associated immune protection by vaccination with mRNA transfected dendritic cells

artículo científico publicado en 2003

Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants

artículo científico publicado en 2016

Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy.

artículo científico publicado en 2012

Getting by with a little help from the right CD4(+) T cells.

artículo científico publicado en 2013

Glioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes.

artículo científico publicado en 2016

Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs.

artículo científico publicado en 2005

Hypoxia and antitumor CD8+ T cells: An incompatible alliance?

artículo científico publicado en 2016

Identification of a novel population of highly cytotoxic c-Met-expressing CD8+ T lymphocytes.

artículo científico publicado en 2017

Immune escape of gliomas.

artículo científico publicado en 2001

Immunobiology of Gliomas: New Perspectives for Therapy ⬇️

artículo científico publicado el 17 de septiembre de 1997

Immunotherapy for glioma: from illusion to realistic prospects?

artículo científico

Immunotherapy of Brain Tumors.

artículo científico

Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?

artículo científico publicado en 2016

Lentiviral transduction of dendritic cells confers protective antiviral immunity in vivo

artículo científico publicado en 2004

Loss of Fas (CD95/APO-1) expression by antigen-specific cytotoxic T cells is reversed by inhibiting DNA methylation.

artículo científico publicado en 2000

Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapies.

artículo científico publicado en 2013

Mechanistic insights into the efficacy of cell penetrating peptide-based cancer vaccines.

artículo científico publicado en 2018

Memory TCR repertoires analyzed long-term reflect those selected during the primary response

artículo científico publicado en 1996

Modulation of Epstein-Barr virus-induced B-cell activation by concanavalin A.

artículo científico publicado en 1985

Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell-Mediated Antitumor Immunity

artículo científico publicado en 2015

Peripheral tolerance limits CNS accumulation of CD8 T cells specific for an antigen shared by tumor cells and normal astrocytes.

artículo científico publicado en 2008

Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells

artículo científico publicado en 2015

Preferential expression of very late antigen-4 on type 1 CTL cells plays a critical role in trafficking into central nervous system tumors

scientific article published on 01 July 2007

Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen.

artículo científico publicado en 2003

Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: a high magnitude CD8 response is comprised of very few clones.

artículo científico publicado en 1996

Sister cytotoxic CD8+ T cell clones differing in natural killer inhibitory receptor expression in human astrocytoma.

artículo científico publicado en 2002

Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumours

artículo científico publicado en 2013

T-cell immune responses in the brain and their relevance for cerebral malignancies

artículo científico publicado en 2003

T-cell immunotherapy for malignant glioma: toward a combined approach.

artículo científico publicado en 2010

TCR analysis reveals significant repertoire selection during in vitro lymphocyte culture.

artículo científico publicado en 1997

The CD40/CD40L axis in glioma progression and therapy

artículo científico publicado en 2015

The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity

artículo científico publicado en 2013

Tissue homing and persistence of defined antigen-specific CD8+ tumor-reactive T-cell clones in long-term melanoma survivors

artículo científico publicado en 2006

Tumor expression of Fas ligand (CD95L) and the consequences

artículo científico publicado en 1998

Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity

artículo científico publicado en 2002

Lista de obras de

A quantitative, single-cell PCR analysis of an antigen-specific TCR repertoire selected during an in vivo CD8 response: direct evidence for a wide range of clone sizes with uniform tissue distribution.

Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset.

B7-homolog 1 expression by human glioma: a new mechanism of immune evasion.

Brain tumor immunotherapy: Illusion or hope?

Cell-penetrating peptides-the Swiss Army knife of cancer vaccines.

Cutting edge: cross-presentation as a mechanism for efficient recruitment of tumor-specific CTL to the brain.

Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing

ER-mitochondria contacts control surface glycan expression and sensitivity to killer lymphocytes in glioma stem-like cells.

Efficient induction of CD8 T-associated immune protection by vaccination with mRNA transfected dendritic cells

Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants

Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy.

Getting by with a little help from the right CD4(+) T cells.

Glioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes.

Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs.

Hypoxia and antitumor CD8+ T cells: An incompatible alliance?

Identification of a novel population of highly cytotoxic c-Met-expressing CD8+ T lymphocytes.

Immune escape of gliomas.

Immunobiology of Gliomas: New Perspectives for Therapy ⬇️

Immunotherapy for glioma: from illusion to realistic prospects?

Immunotherapy of Brain Tumors.

Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?

Lentiviral transduction of dendritic cells confers protective antiviral immunity in vivo

Loss of Fas (CD95/APO-1) expression by antigen-specific cytotoxic T cells is reversed by inhibiting DNA methylation.

Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapies.

Mechanistic insights into the efficacy of cell penetrating peptide-based cancer vaccines.

Memory TCR repertoires analyzed long-term reflect those selected during the primary response

Modulation of Epstein-Barr virus-induced B-cell activation by concanavalin A.

Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell-Mediated Antitumor Immunity

Peripheral tolerance limits CNS accumulation of CD8 T cells specific for an antigen shared by tumor cells and normal astrocytes.

Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells

Preferential expression of very late antigen-4 on type 1 CTL cells plays a critical role in trafficking into central nervous system tumors

Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen.

Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: a high magnitude CD8 response is comprised of very few clones.

Sister cytotoxic CD8+ T cell clones differing in natural killer inhibitory receptor expression in human astrocytoma.

Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumours

T-cell immune responses in the brain and their relevance for cerebral malignancies

T-cell immunotherapy for malignant glioma: toward a combined approach.

TCR analysis reveals significant repertoire selection during in vitro lymphocyte culture.

The CD40/CD40L axis in glioma progression and therapy

The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity

Tissue homing and persistence of defined antigen-specific CD8+ tumor-reactive T-cell clones in long-term melanoma survivors

Tumor expression of Fas ligand (CD95L) and the consequences

Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity